CryoPort (CYRX)
(Delayed Data from NSDQ)
$7.03 USD
+1.48 (26.67%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $7.03 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Brokerage Reports
CryoPort, Inc. [CYRX]
Reports for Purchase
Showing records 1 - 20 ( 195 total )
Company: CryoPort, Inc.
Industry: Transportation - Services
10th Annual ROTH London Conference Software Participants
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Rationalizing Growth Vectors and Costs Is a Material Positive
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Slow Growth and Fast Investments Weigh on Near-Term PL
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Modest 2H23 Returns Add To Fair 1H23 Returns; 2024 Poised for Material Rebound
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Optimized Entry and Exit Levels for CYRX 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
3Q23 Suggests Cell Gene Therapy Market Has Bottomed
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Technology -12th Annual New York Technology Conference Preview - November 15th
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Facility Tour - Compelling Perspective on Cell and Gene Therapy Market
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
Company: CryoPort, Inc.
Industry: Transportation - Services
2Q23 - Long-Term Outlook on Cell Therapy Market Seems Unchanged
Provider: KeyBanc Capital Markets
Analyst: Research Department